# Cochrane Risk of Bias 2 (RoB 2) Assessment

## Study & Result Information
- **Study Citation:** Lee D, et al. Needle-Free Electroacupuncture for Postoperative Pain Management: A Double-Blind, Sham and Different Intervention Controlled Clinical Experimental Design. *Evidence-Based Complementary and Alternative Medicine*. 2011;2011:696754.
- **Source Document in Google Drive:** `049_lee_2011.pdf`
- **Trial Registration:** Not reported / omitted in text
- **Population:** 47 female patients undergoing total abdominal hysterectomy under general anesthesia.
- **Intervention (Group 3 & 4):** Needle-free EA at bilateral Zusanli (ST36), Sanyinjiao (SP6), and Shenshu (BL23) pre- and postoperatively: Group 3 = High frequency 100 Hz (n = 12); Group 4 = Low frequency 2 Hz (n = 10).
- **Comparator 1 (Group 2 - Sham):** Identical electrodes placed at non-acupoints with inactive stimulation (n = 12).
- **Comparator 2 (Group 1 - Control):** Conventional care alone (n = 13).
- **Assessed Outcome:** Total Postoperative PCA Morphine Doses
- **Assessed Timepoint:** 24 hours postoperatively
- **Numerical Result:** 
  - Group 1 (Control, n = 13): Mean 15.58 ± 7.91 doses
  - Group 2 (Sham, n = 12): Mean 14.58 ± 7.27 doses
  - Group 3 (High-EA, n = 12): Mean 6.92 ± 3.82 doses
  - Group 4 (Low-EA, n = 10): Mean 11.00 ± 6.09 doses
  - One-way ANOVA: $F(3, 43) = 4.41$, $P = 0.008$ (p. 4)

---

### Step 1: Study Design Verification
- **Experimental Design:** 4-arm randomized, double-blind, sham-controlled parallel trial.
- **Unit of Randomization:** Individual patient.

---

### Step 2: Signaling Questions & Domain Evaluations

#### Domain 1: Risk of bias arising from the randomization process
- **1.1 Random sequence generation:** Yes (Y) — "randomly assigned... A random number table was used to allocate the participants into four groups" (`049_lee_2011.pdf`, p. 2, col. 1).
- **1.2 Allocation concealment:** Probably Yes (PY) — "group assignments were kept fully blinded from the subjects and data collectors... in numbered order, as they became available" (p. 2, col. 1).
- **1.3 Baseline balance:** No (N) — Age (42.02 ± 8.31 yr), weight (59.74 ± 17.54 kg), surgical duration, and anesthesia time balanced ($P > 0.05$; Table 2).
- **Domain 1 Judgment:** **Low Risk of Bias**

#### Domain 2: Risk of bias due to deviations from the intended interventions
- **2.1 Participant awareness:** Probably No (PN) — "double-blind, sham... Neither the subjects nor the data collectors knew which treatment was administered" (p. 2, col. 1).
- **2.2 Carers awareness:** Probably No (PN) — Ward nurses and data collectors were blinded.
- **2.3 Contextual deviations:** No (N) — Standardized IV-PCA morphine: 1 mg bolus, 8-min lockout.
- **2.5 Appropriate analysis:** Yes (Y) — All 47 enrolled and randomized subjects completed the study and were analyzed.
- **Domain 2 Judgment:** **Low Risk of Bias**

#### Domain 3: Risk of bias due to missing outcome data
- **3.1 Data completeness:** Yes (Y) — 47 of 47 patients (100%) completed 24-h PCA monitoring.
- **Domain 3 Judgment:** **Low Risk of Bias**

#### Domain 4: Risk of bias in measurement of the outcome
- **4.1 Inappropriate measurement:** No (N) — Electronic PCA pump records.
- **4.2 Differ between groups:** No (N)
- **4.3 Assessors aware:** No (N) — Assessors and data collectors were strictly blinded.
- **Domain 4 Judgment:** **Low Risk of Bias**

#### Domain 5: Risk of bias in selection of the reported result
- **5.1 Pre-specified analysis plan:** No Information (NI) — Registry identifier not reported.
- **5.2 Result selected:** Probably No (PN) — PCA demand and delivered doses reported.
- **5.3 Multiple analyses:** Probably No (PN)
- **Domain 5 Judgment:** **Some Concerns** (unregistered protocol).

---

### Step 3: Overall Judgment & Summary Table

| Domain | Judgment | Key Supporting Rationale |
|---|:---:|---|
| **Domain 1: Randomization Process** | **Low** | Random number table; numbered sequential allocation; balanced baseline. |
| **Domain 2: Deviations from Intended Interventions** | **Low** | Double-blind sham-controlled design; blinded patients and ward assessors. |
| **Domain 3: Missing Outcome Data** | **Low** | 100% complete data (47/47 analyzed). |
| **Domain 4: Measurement of the Outcome** | **Low** | Blinded data collectors; electronic PCA device logs. |
| **Domain 5: Selection of the Reported Result** | **Some concerns** | Protocol registration not reported. |
| **OVERALL RISK OF BIAS** | **SOME CONCERNS** | Driven by Domain 5. |

---

### Step 4: Evidence Audit
- `049_lee_2011.pdf`, p. 2, col. 1: "Neither the subjects nor the data collectors knew which treatment was administered... random number table was used".
- `049_lee_2011.pdf`, p. 4, col. 1: "total patient-controlled analgesia demand and doses indicated significant differences: Group 1 15.58 ± 7.91, Group 2 14.58 ± 7.27, Group 3 6.92 ± 3.82, Group 4 11.00 ± 6.09, F = 4.41, P = 0.008."

---

### Step 5: Author Contact Flags
- Request prospective trial registration identifier.

---

### Step 6: Final Structured Extraction
```json
{
  "study_id": "Lee_2011",
  "source_file": "049_lee_2011.pdf",
  "outcome": "Total Postoperative PCA Morphine Doses",
  "timepoint": "24 hours postoperative",
  "sample_size": {"group_1": 13, "group_2": 12, "group_3": 12, "group_4": 10, "total": 47},
  "result": {"control_mean": 15.58, "control_sd": 7.91, "sham_mean": 14.58, "sham_sd": 7.27, "high_ea_mean": 6.92, "high_ea_sd": 3.82, "low_ea_mean": 11.00, "low_ea_sd": 6.09, "p_value": 0.008},
  "overall_rob": "Some concerns"
}
```
